Innovation
Why Should Economic Evaluations of Medical Innovations Have a Societal Perspective?
1 October 2009
In this Briefing, five leading European experts in health economics provide a comprehensive international review of changes in health economic evaluation and the reasons for them. …
The Many Faces of Innovation
2 January 2005
The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at…
Consolidation and Competition in the Pharmaceutical Industry
9 January 2001
A number of potentially important structural developments are taking place in the pharmaceutical industry. On the one hand, we are witnessing a large number of mergers…
The Road to Sustainability in the UK and German Biotechnology Industries
1 August 2000
The UK and Germany are the European leaders in biotechnology. They have many more companies and employees in biotechnology, and much greater sums invested in biotechnology…
Surgical Research and Development in the NHS – Promotion, Management and Evaluation
1 July 2000
Based on papers delivered at the OHE Conference, London, 25 November 1997. Based on papers delivered at the OHE Conference, London, 25 November 1997. The UK…
Primary Care and the NHS Reforms: A Manager’s View
1 March 2000
Writing on the future of Primary Care Groups/Trusts, and of Labour’s health service reforms in general, invites subsequent ridicule by those blessed with the clarity of…
The New NHS: What Can We Learn From Managed Care in New Zealand and the US?
1 July 1999
• The integration of health care is the defining theme of policy developments in the UK, US and New Zealand. The common element between the three…
Competition through Innovation, Innovation through Competition
1 November 1998
Pharmaceutical companies report that in their dynamic, research and technology intensive industry, competitiveness is synonymous with innovativeness. That is, companies must invest in product research and…
National Health Service Reorganisation: Learning from History?
1 January 1998
I am greatly flattered to be invited to deliver the 1998 annual lecture of the Office of Health Economics, partly on account of my distinguished predecessors,…